Singapore: CellResearch Corporation explores 2019 Nasdaq listing

HiFiBiO Therapeutics
A biological testing process underway at a personal products lab. Photo: Bloomberg

Singapore-based CellResearch Corporation (CellResearchCorp), a biotechnology firm specialising in stem cell research aimed at wound treatments, is considering a listing on the New York-based Nasdaq in 2019 as part of its plans to establish a global footprint.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe